Persistent Pulmonary Hypertension of Non Cardiac Cause in a Neonatal Intensive Care Unit

Table 3

Treatment (𝑛=78).

Inhaled nitric oxide, 𝑛 (%)	19 (24.3%)
Surfactant, 𝑛 (%)	24 (30.7%)
Dopamine, 𝑛 (%)	57 (73%)
Dobutamine, 𝑛 (%)	35 (44.8%)
Epinephrine, 𝑛 (%)	3 (3.8%)
Sildenafil, 𝑛 (%)	12 (15.3%)
Diuretics, 𝑛 (%)	33 (42.3%)
Sedation, 𝑛 (%)	71 (91%)
Oxygen, 𝑛 (%)	78 (100%)
Days of oxygen, median (min–max)	6 (1–114)
Mechanical ventilation, 𝑛 (%)	71 (91%)
Days of mechanical ventilation, median (min–max)	7 (1–114)
Extracorporeal membrane	1 (1.2%)
oxygenation (ECMO), 𝑛 (%)
Days of ECMO	17